Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial.

MLA

Huang, Xiaofei, et al. “Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial.” Gut and Liver, vol. 18, no. 5, Sept. 2024, pp. 906–14. EBSCOhost, https://doi.org/10.5009/gnl230326.

APA

Huang, X., Mao, W., Hu, X., Qin, F., Zhao, H., Zhang, A., Wang, X., Stoppe, C., Zhou, D., Ke, L., & Ni, H. (2024). Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial. Gut and Liver, 18(5), 906–914. https://doi.org/10.5009/gnl230326

Chicago

Huang, Xiaofei, Wenjian Mao, Xingxing Hu, Fengxia Qin, Hui Zhao, Aiping Zhang, Xinyu Wang, et al. 2024. “Immune-Enhancing Treatment among Acute Necrotizing Pancreatitis Patients with Metabolic Abnormalities: A Post Hoc Analysis of a Randomized Clinical Trial.” Gut and Liver 18 (5): 906–14. doi:10.5009/gnl230326.